TrialThe Lancet. Respiratory medicine2021

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.

Laurie A Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.